Following the recent BRAVE-AA trials Olumiant (baricitinib) has become the first USFDA approved systemic treatment (i.e. treats the entire body rather than a specific location) for Alopecia Areata. About the new Drug (Baricitinib) Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited.
Dr. Doireann discusses all things health, lifestyle and well-being, sharing important messages on healthy living with her listeners. Follow her podcast here. The aim of Dr Dorieann’s podcast is to share medical information in an easy and understandable way. She ask the experts the questions and they share the facts. In one of two episodes
The hair loss condition Alopecia Areata was thrown into the headlines in recent times when Chris Rock made an inappropriate joke about Jada Pinkett Smith’s shaved head at the Oscars. Jada was visibly upset following the comment. Jada has been open about her journey with Alopecia Areata over recent years and in 2021 explained that
HRBR is delighted to welcome Dr Dmitri Wall, Consultant Dermatologist, to the team of hair specialists at HRBR. With the addition of Dr Wall, HRBR will now provide a dermatology clinic offering consultations for patients suffering from conditions of the hair and scalp that may not be suitable for treatment with hair transplant surgery. Patients
Please send all referrals to referrals@hrbr.ie.
For media and press enquiries please contact Michael
Your contact details and all information submitted below will be treated as strictly private and confidential. They will only be used for internal HRBR use.
